Endotronix
Latest round
- Series D
Last raised
- Sep 2018
Total raised
- $52M
Investors
- 8
About Endotronix
Based in the US, Endotronix, Inc.Endotronix, Inc. focuses on heart failure management through its flagship product, the Cordella Pulmonary Artery (PA) Sensor System, which provides critical data for patient care. Founded in 2007 in Naperville, US, the company has undergone strategic pivots to enhance its offerings. Co-founders Anthony Nunez, Harry Rowland, and Michael Nagy have contributed to its development, with Harry Rowland currently serving as CEO.Endotronix, Inc. primarily focuses on advancing heart failure management through its core offering, the Cordella Pulmonary Artery (PA) Sensor System. This FDA-approved medical device measures, records, and transmits pulmonary artery pressure data for patients with New York Heart Association (NYHA) Class III heart failure. The system enables remote monitoring and proactive management of heart failure by providing clinicians with comprehensive patient health data, including pulmonary artery pressure, blood pressure, weight, heart rate, and blood oxygen levels.Endotronix generates revenue through the sales of its Cordella PA Sensor System and associated services, focusing on a direct-to-consumer model targeted at healthcare institutions and clinics. The company's transactions include partnership agreements with healthcare providers and may explore subscription models for continuous monitoring services, facilitating ongoing support and data analysis for patients. The revenue model emphasizes integrating the Cordella system into existing care pathways, allowing clinicians to utilize real-time health data for effective treatment adjustments.Endotronix, Inc. plans to enhance its product offerings and expand into new markets. It aims to design and launch upcoming products that further improve heart failure management, though specific release dates are not detailed.S. and Europe.
Who invested in Endotronix
8 investors across 2 rounds
See all investors in Endotronix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Endotronix
Who invested in Endotronix?
Endotronix has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Endotronix raised?
Endotronix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Endotronix last raise money?
Endotronix's most recent round on record is a Series D, in Sep 2018.
What does Endotronix do?
Based in the US, Endotronix, Inc.
Where is Endotronix headquartered?
Endotronix is headquartered in Naperville, US.
Which VCs invest in companies like Endotronix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Endotronix's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Endotronix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.